All News

The Food and Drug Administration lifted a partial clinical hold on the CANOVA trial, examining Venclexta plus dexamethasone for some patients with relapsed/refractory myeloma.

It’s easy for a person with breast cancer to feel overwhelmed by the many thoughts that enter the mind each day but there are techniques that can prove helpful. One survivor shares some of her own helpful tips.

Techniques, such as stop, shift and stabilize, may help cancer survivors avoid stressful exchanges with coworkers, according to one expert.

Why this breast cancer survivor thinks more oncologists should be listening carefully to patients on social media.

How to respond to others that pull away after the cancer diagnosis.

The FDA has granted a priority review designation to a supplemental biologics license application for Zejula for the treatment of certain patients with advanced ovarian, fallopian tube or primary peritoneal cancer.

Experts offered tips on quick, healthy office meals and snacks while fighting cancer’s side effects.

Don't let anyone else decide how you choose to celebrate any post-cancer milestones.

The Aplastic Anemia & MDS International Foundation presented its first Lifetime Achievement in Science Award to Mary Horowitz, MD, MS at the Foundation’s 35th Anniversary Luncheon and Awards Program on May 18, 2019. Dr. Horowitz was honored for the significant impact her work has had on stem cell transplant and hematologic malignancy practice worldwide.

In the second part of our Q&A with Chris Williams, of the Multiple Myeloma Research Foundation, we spoke with him about the past, present and future of the myeloma landscape.

Cancer is a huge, life-changing event for a family and the power of the experience in a young person’s life should not be underestimated. What is a semester at college compared to the learning and self-understanding that comes from being with your family in such a stressful time?

Breast cancer survivorship is something to celebrate and there are many ways to commemorate the fact, but are t-shirts and other items the best way to honor survivors? One survivor shares her perspective and reflects on National Cancer Survivor’s Day.

From cancer-sniffing dogs to music therapy for pain, here’s what is making headlines in the cancer space this week.

The growing use of immunotherapy in oncology has confronted many community practice-based oncologists with challenges to implementation, but one advocacy group’s new initiative aims to educate and empower.

I have a daily calendar on my desk with very wise sayings. One that really stood out was by J.C.Watts. “It doesn’t take a lot of strength to hang on. It takes a lot of strength to let go.”

Many survivors face times of worry and anxiety. An upcoming appointment, a scan, a new lump, bump or spot can all be triggers for feeling intense anxiety. Here are three simple tools from a fellow survivor to help cope in those times.

In the first part of our Q&A with Chris Williams, of the Multiple Myeloma Research Foundation, we spoke with him on the current initiatives and resources available to patients.

Routine use of prophylactic radiotherapy in patients with malignant pleural mesothelioma is unnecessary following a chest wall procedure, according to multicenter, open-label, phase 3, randomized controlled trial findings published in the Journal of Clinical Oncology.

Mindfulness and meditation for the masses. What does this mean to those of us with a life-threatening disease?

Even a cancer survivor with an upbeat attitude can experience bittersweet blues sometimes out of the blue. There are ways to learn from this feeling, whatever we call it, and keep on going.

Results from a clinical trial in people with mesothelioma indicate that an experimental chimeric antigen receptor-T cell therapy is safe and may provide benefit to patients, especially in combination with other immunotherapies.

Can fitness make you physically prepared for a medical detour?

Patients with chronic lymphocytic leukemia should learn about the latest advancements, says one expert.

The Food and Drug Administration approved Keytruda for the treatment of patients with metastatic small cell lung cancer.

Maintenance therapy with defactinib failed to improve survival following front-line chemotherapy in patients with merlin-low malignant pleural mesothelioma, according to results from the phase 2 COMMAND trial.

A novel imaging test developed at UT Southwestern may help to determine which patients with kidney cancer would benefit from treatment with immunotherapy.

Getting back up matters when cancer knocks you down, but so does pausing for reflection.

Autoimmune skin toxicities in patients with non-small cell lung cancer mean patients may respond better to immune checkpoint inhibitors.